N6-Methyladenosine (m<sup>6</sup>A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma

<div>Construction of the risk model based on m6A-related lncRNAs for LUSC patients. (a) Sankey diagrams of 23 m<sup>6</sup>A genes and m<sup>6</sup>A-related lncRNAs. (b)-(c) Least absolute shrinkage and selection operator (LASSO) analysis of 16 m<sup>6</sup>A-related lncRNAs that affected prognostic. Establishment of the m6A-related lncRNAs risk model.</div>

Journal of Oncology

fig1

Figure 1

Figure 1: N6-Methyladenosine (m<sup>6</sup>A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma 

Figure 1 | N6-Methyladenosine (m6A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma 